APA (7th ed.) Citation

Hu, X., Li, Y., Li, Q., Ma, Y., Peng, J., & Cai, S. (2018). Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway. BMC.

Chicago Style (17th ed.) Citation

Hu, Xiang, Ya-Qi Li, Qing-Guo Li, Yan-Lei Ma, Jun-Jie Peng, and San-Jun Cai. Osteoglycin (OGN) Reverses Epithelial to Mesenchymal Transition and Invasiveness in Colorectal Cancer via EGFR/Akt Pathway. BMC, 2018.

MLA (8th ed.) Citation

Hu, Xiang, et al. Osteoglycin (OGN) Reverses Epithelial to Mesenchymal Transition and Invasiveness in Colorectal Cancer via EGFR/Akt Pathway. BMC, 2018.